RPRX
Royalty Pharma
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: RPRX
- PE Ratio
The price-to-earnings ratio for Royalty Pharma stock stands at 28.05 as of Jun 22, 2026. This is based on the current EPS of $1.91 and the stock price of $53.57 per share. An increase of 36% has been recorded in the PE ratio compared to the average of 20.6 of the last four quarters.
RPRX PE ratio history
Over the last six years, the average PE ratio of Royalty Pharma has been 43.86. The current 28.05 P/E ratio is 36% lower than the historical average. In the past six years, RPRX's PE ratio peaked in the Dec 2022 quarter at 395.2, with a price of $39.52 and an EPS of $0.1. The Sep 2024 quarter marked the lowest point at 11.01, with a price of $28.29 and an EPS of $2.57.
Royalty Pharma PE ratio by year
Maximum annual increase: 1,377.94% in 2022
Maximum annual decrease: -97.2% in 2023
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 21.59 | 62.45% | $38.64 | $1.79 |
| 2024 | 13.29 | 20.16% | $25.51 | $1.92 |
| 2023 | 11.06 | -97.2% | $28.09 | $2.54 |
| 2022 | 395.2 | 1,377.94% | $39.52 | $0.1 |
| 2021 | 26.74 | -29.48% | $39.85 | $1.49 |
| 2020 | 37.92 | N/A | $50.05 | $1.32 |
| 2019 | N/A | N/A | N/A | N/A |
| 2018 | N/A | N/A | N/A | N/A |
| 2017 | N/A | N/A | N/A | N/A |
Royalty Pharma PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 25.12 | 16.35% | $47.97 | $1.91 |
| Dec 2025 | 21.59 | 7.68% | $38.64 | $1.79 |
| Sep 2025 | 20.05 | 28.53% | $35.28 | $1.76 |
| Jun 2025 | 15.6 | 23.81% | $36.03 | $2.31 |
| Mar 2025 | 12.6 | -5.19% | $31.13 | $2.47 |
| Dec 2024 | 13.29 | 20.71% | $25.51 | $1.92 |
| Sep 2024 | 11.01 | -36.94% | $28.29 | $2.57 |
| Jun 2024 | 17.46 | 2.89% | $26.37 | $1.51 |
| Mar 2024 | 16.97 | 53.44% | $30.37 | $1.79 |
| Dec 2023 | 11.06 | -84.11% | $28.09 | $2.54 |
| Sep 2023 | 69.59 | 24.51% | $27.14 | $0.39 |
| Jun 2023 | 55.89 | 14.79% | $30.74 | $0.55 |
| Mar 2023 | 48.69 | -87.68% | $36.03 | $0.74 |
| Dec 2022 | 395.2 | 1,021.13% | $39.52 | $0.1 |
| Sep 2022 | 35.25 | -11.12% | $40.18 | $1.14 |
RPRX Price vs fair value
RPRX average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, RPRX's PE ratio is higher than its 3-year historical average, but it is lower than the 5-year average.
PE comparison
With a P/E of 28.05, RPRX stands above the Healthcare sector and the industry average. In comparison with its Healthcare sector average of 24.1, Royalty Pharma's P/E is 16% higher.
RPRX PE vs peers
RPRX's PE ratio stands lower than its peer stock LLY, but it is higher than ABT's and ANIP's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| ANIP Ani Pharmaceuticals Inc | 20.17 | $1.89B |
| ABT Abbott Laboratories | 25.19 | $157.49B |
| RPRX Royalty Pharma plc | 28.98 | $31.87B |
| LLY ELI LILLY & Co | 39.19 | $1.04T |
Frequently asked questions
What is Royalty Pharma's PE ratio?
The price to earnings ratio for RPRX stock as of Jun 22, 2026, stands at 28.05.
What is the 3-year average PE ratio for Royalty Pharma (RPRX)?
The 3-year average price to earnings ratio for RPRX stock is 24.19.
What is the 5-year average PE ratio for Royalty Pharma (RPRX)?
The 5-year average price to earnings ratio for RPRX stock is 44.9.
What is the highest PE ratio for RPRX?
The highest quarterly PE ratio in the last six years has been 395.2 and it was in the Dec 2022 quarter.
How does the current PE ratio for RPRX compare to its historical average?
RPRX's current price to earnings ratio is 36% below its 6-year historical average.
How is RPRX's PE ratio calculated (Royalty Pharma PE ratio formula)?
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Jun 22, 2026), Royalty Pharma's stock price is $53.57. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $1.91. Therefore, Royalty Pharma's PE ratio for today is 28.05. PE RATIO(28.05) = STOCK PRICE($53.57) / TTM EPS($1.91)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.